Overview

Blood Naloxone Levels Following Intradermal Injection in Humans

Status:
Not yet recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate pharmacokinetics/pharmacodynamics of intradermal administration of naloxone in healthy adult subjects.
Phase:
Phase 4
Details
Lead Sponsor:
Johns Hopkins University
Collaborator:
DEKA S.r.l.
Treatments:
Naloxone